These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8414287)

  • 21. Interaction of griseofulvin and oral contraceptives.
    Côté J
    J Am Acad Dermatol; 1990 Jan; 22(1):124-5. PubMed ID: 2298948
    [No Abstract]   [Full Text] [Related]  

  • 22. Oral contraceptive interaction with cyclosporin.
    Deray G; le Hoang P; Cacoub P; Assogba U; Grippon P; Baumelou A
    Lancet; 1987 Jan; 1(8525):158-9. PubMed ID: 2879990
    [No Abstract]   [Full Text] [Related]  

  • 23. [A clinical study of the triphasic contraceptive Tri-Regol].
    Rachev E
    Akush Ginekol (Sofiia); 1995; 34(2):64-5. PubMed ID: 8651433
    [No Abstract]   [Full Text] [Related]  

  • 24. Observations with anteovin in dermatological disorders.
    Vánkos J
    Ther Hung; 1986; 34(4):204-11. PubMed ID: 2966994
    [No Abstract]   [Full Text] [Related]  

  • 25. Confusion between oral contraceptives and oestrogen replacement preparations.
    Levinsohn DG
    S Afr Med J; 1988 Jul; 74(2):89. PubMed ID: 3399985
    [No Abstract]   [Full Text] [Related]  

  • 26. Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.
    Brenner P
    Contraception; 2006 Oct; 74(4):354; author reply 354-5. PubMed ID: 16982246
    [No Abstract]   [Full Text] [Related]  

  • 27. Lack of effect of tenofovir disoproxil fumarate on pharmacokinetics of hormonal contraceptives.
    Kearney BP; Mathias A
    Pharmacotherapy; 2009 Aug; 29(8):924-9. PubMed ID: 19637945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The risk of unintended pregnancies in users of the contraceptive patch compared to users of oral contraceptives in the UK General Practice Research Database.
    Jick SS; Hagberg KW; Kaye JA; Jick H
    Contraception; 2009 Aug; 80(2):142-51. PubMed ID: 19631789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Norgestrel-ethinyl estradiol--an oral contraceptive. A clinical study of 725 patients.
    Hernandez-Torres A; Satterthwaite AP
    Am J Obstet Gynecol; 1970 Sep; 108(2):183-7. PubMed ID: 4952920
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hormonal contraceptives in female rowers].
    Lisý Z
    Cas Lek Cesk; 1984 Aug; 123(35):1086-90. PubMed ID: 6498900
    [No Abstract]   [Full Text] [Related]  

  • 31. A review of post-marketing safety and surveillance data for oral contraceptives containing norgestimate and ethinyl estradiol.
    Lippman JS; Shangold GA
    Int J Fertil Womens Med; 1997; 42(4):230-9. PubMed ID: 9309456
    [No Abstract]   [Full Text] [Related]  

  • 32. [A patient with a large liver tumor and long-term use of oral contraceptives].
    Scheurlen C; Mannes GA; Sauerbruch T; Moser E
    Internist (Berl); 1985 Dec; 26(12):789-93. PubMed ID: 3936820
    [No Abstract]   [Full Text] [Related]  

  • 33. Contraception update.
    Lindahl SH
    Adv NPs PAs; 2011 Jan; 2(1):31-4. PubMed ID: 21329230
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of oral contraceptive agents on serum fructosamine.
    Mitchell TH; O'Brien M; Harling LF; Paterson CS
    Diabetes Care; 1990 Jul; 13(7):815-6. PubMed ID: 2387204
    [No Abstract]   [Full Text] [Related]  

  • 35. [Massive, painful hepatomegaly, sinusoidal dilatation and prolonged use of estroprogestational agents].
    Fischer D; Kémény F; Rauturseau J; Marty M; Karsenti P
    Gastroenterol Clin Biol; 1982 Mar; 6(3):302-4. PubMed ID: 7095347
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparative effects of a contraceptive vaginal ring delivering a nonandrogenic progestin and continuous ethinyl estradiol and a combined oral contraceptive containing levonorgestrel on hemostasis variables.
    Rad M; Kluft C; Ménard J; Burggraaf J; de Kam ML; Meijer P; Sivin I; Sitruk-Ware RL
    Am J Obstet Gynecol; 2006 Jul; 195(1):72-7. PubMed ID: 16545330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Femodene/Minulet--how different is gestodene?
    Drug Ther Bull; 1990 May; 28(11):41-2. PubMed ID: 2131208
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of menstrual disorders with a combination of norgestrel and ethynyl estradiol.
    Rao KP
    Curr Med Pract; 1971; 15(1):586-9. PubMed ID: 12306340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of an oral contraceptive on serum phosphohexose isomerase activity.
    Gupta U; Khuteta KP; Gupta RC
    Indian J Physiol Pharmacol; 1983; 27(3):253-4. PubMed ID: 6668056
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.